[HTML][HTML] Expanded PCR Panel Testing for Identification of Respiratory Pathogens and Coinfections in Influenza-like Illness

P Upadhyay, J Reddy, T Proctor, O Sorel…�- Diagnostics, 2023 - mdpi.com
While COVID-19 has dominated Influenza-like illness (ILI) over the past few years, there are
many other pathogens responsible for ILI. It is not uncommon to have coinfections with�…

Risk Analysis of Respiratory Syncytial Virus Among Infants in the United States by Birth Month

JR Gantenberg, R van Aalst…�- Journal of the�…, 2024 - academic.oup.com
Background Respiratory syncytial virus (RSV) is a major cause of morbidity and mortality
among US infants. A child's calendar birth month determines their age at first exposure (s) to�…

Equitable Access to RSV Prevention: Challenges and Opportunities With Nirsevimab's Rollout

YT Yang, SS DeRoo�- Journal of Public Health Management and�…, 2024 - journals.lww.com
The recent approval of nirsevimab (Beyfortus) marks a pivotal step in the prevention of
respiratory syncytial virus (RSV) infections in young children. As the leading cause of infant�…

[HTML][HTML] COVID-19, Influenza, and RSV in Children and Adults: A Clinical Comparative Study of 12,000 Cases

JH Kwon, SH Paek, SH Park, MJ Kim, YH Byun…�- Journal of Clinical�…, 2024 - mdpi.com
(1) Background: Respiratory virus infections, including Coronavirus disease 2019 (COVID-
19), seasonal influenza (FLU), and respiratory syncytial virus (RSV) as prominent examples�…

[HTML][HTML] Trends in RSV testing patterns among infants presenting with bronchiolitis: Results from four United States health systems, 2015-2023

AZ Blatt, M Suh, EB Walter, CT Wood, C Espinosa…�- Annals of�…, 2024 - Elsevier
Background Bronchiolitis due to respiratory syncytial virus (RSV) is the leading cause of
hospitalization among American infants. The overall burden of RSV among infants has been�…

Geographic Progression of Infant Respiratory Syncytial Virus Associated Bronchiolitis Across the United States Before and Since the Onset of COVID‐19: Results�…

AZ Blatt, M Suh, EB Walter Jr, CT Wood…�- Influenza and Other�…, 2024 - Wiley Online Library
Background Respiratory syncytial virus (RSV) is a substantial cause of infant morbidity and
mortality due to seasonal peaks of bronchiolitis across the United States. Clinical and viral�…

Nirsevimab immunization's real‐world effectiveness in preventing severe bronchiolitis: A test‐negative case–control study

M Ag�era, A Soler‐Garcia, C Alejandre…�- Pediatric Allergy and�…, 2024 - Wiley Online Library
Background Several clinical trials have shown that nirsevimab, an antibody targeting the
respiratory syncytial virus (RSV), reduces RSV bronchiolitis requiring admission. In 2023�…

[HTML][HTML] Optimal site of care for administration of extended half-life respiratory syncytial virus (RSV) antibodies to infants in the United States (US)

CB Nelson, BL Brady, M Richards, CR Lew, W La Via…�- Vaccine, 2023 - Elsevier
Introduction New extended half-life antibodies for the single-dose prevention of medically
attended (MA) respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) have�…

[HTML][HTML] Pediatric human nose organoids demonstrate greater susceptibility, epithelial responses, and cytotoxicity than adults during RSV infection

GM Aloisio, D Nagaraj, AM Murray, EM Schultz…�- bioRxiv, 2024 - ncbi.nlm.nih.gov
Respiratory syncytial virus (RSV) is a common cause of respiratory infections, causing
significant morbidity and mortality, especially in young children. Why RSV infection in�…

[HTML][HTML] Characteristics and outcomes of pregnant women hospitalized with laboratory-confirmed respiratory syncytial virus before and during the COVID-19 pandemic

J Milucky, K Patel, ME Patton, PD Kirley…�- Open Forum�…, 2024 - academic.oup.com
Background Respiratory syncytial virus (RSV) can cause severe disease among infants and
older adults. Less is known about RSV among pregnant women. Methods To analyze�…